Home Recombination‑negative, immune‑enhanced, and clinically‑attenuated PRRSV as a vaccine platform

Projects

Recombination‑negative, immune‑enhanced, and clinically‑attenuated PRRSV as a vaccine platform

Principle Investigator(s)

Planned Completion date: 01/01/2027

Project Status

Active

Principal Investigator(s)

USA

Researcher Organisations

University of Illinois

Source Country

United StatesIconUnited States